Intraindividual comparison of conventional three-dimensional radiotherapy and intensity modulated radiotherapy in the therapy of locally advanced non-small cell lung cancer - A planning study

被引:18
作者
Marnitz, S
Stuschke, M
Bohsung, J
Moys, A
Reng, I
Wurm, R
Budach, V
机构
[1] Univ Klinikum Charite Campus Mitte, Klin & Poliklin Strahlentherapie, D-10117 Berlin, Germany
[2] Univ Klinikum Essen, Klin & Poliklin Strahlentherapie, Essen, Germany
[3] Klin Eichert, Abt Radioonkol & Strahlentherapie, Goppingen, Germany
关键词
non-small cell lung cancer; intensity modulated radiotherapy; dose escalation;
D O I
10.1007/s00066-002-0939-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Local failure is the one of the most frequent cause of tumor related death in Locally advanced non-small cell Lung cancer (LAD-NSCLC). Dose escalation has the promise of increased loco-regional tumor control but is Limited by the tolerances of critical organs. Patients and Methods: To evaluate the potential of IMRT in comparison to conventional three-dimensional conformal planning (3DCRT) dose constraints were defined: Maximum dose (D-max) to spinal cord < 48 Gy, mean Lung dose less than or equal to 24 Gy, D-max esophagus >70 Gy in not more than 5 cm of the total length. For ten patients two plans were compared: (1) 3DCRT with 5 weekly fractions (SD) of 2 Gy to a total dose (TD) of 50 Gy to the planning target volume of second order (PTV2). If the tolerance of the critical organs was not exceeded, patients get a boost plan with a higher TD to the PTV1. (2) IMRT: concomitant boost with 5 weekly SD of 2 Gy (PTV1) and 1.5 Gy to a partial (p)PTV (pPTV = PTV2 boolean AND PTV1) to a TD of 51 Gy to the pPTV and 68 Gy to the PTV1. If possible, patients get a boost plan to the PTV1 with 5 weekly SD of 2 Gy to the highest possibly TD. Results: Using 3DCRT, 3/10 patients could not be treated with TD > 50 Gy, but 9/10 patients get higher TD by IMRT. TD to the PTV1 could be escalated by 16% on average. The use of non-coplanar fields in IMRT Lead to a reduction of the irradiated Lung volume. There is a strong correlation between physical and biological mean lung doses. Conclusion: IMRT gives the possibility of further dose escalation without an increasing mean Lung dose especially in patients with large tumors.
引用
收藏
页码:651 / 658
页数:8
相关论文
共 43 条
[1]   Clinical dose-volume histogram and lung toxicity after irradiation for lung cancer [J].
Abratt, RP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (05) :1461-1461
[2]   Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer [J].
Armstrong, J ;
Raben, A ;
Zelefsky, M ;
Burt, M ;
Leibel, S ;
Burman, C ;
Kutcher, G ;
Harrison, L ;
Hahn, C ;
Ginsberg, R ;
Rusch, V ;
Kris, M ;
Fuks, Z .
RADIOTHERAPY AND ONCOLOGY, 1997, 44 (01) :17-22
[3]   EFFECT OF CHEMOTHERAPY ON LOCALLY ADVANCED NON-SMALL-CELL LUNG-CARCINOMA - A RANDOMIZED STUDY OF 353 PATIENTS [J].
ARRIAGADA, R ;
LECHEVALIER, T ;
QUOIX, E ;
RUFFIE, P ;
DECREMOUX, H ;
DOUILLARD, JY ;
TARAYRE, M ;
PIGNON, JP ;
LAPLANCHE, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 20 (06) :1183-1190
[4]   A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable nonsmall cell lung cancer: final report of an Australian multi-centre trial [J].
Ball, D ;
Bishop, J ;
Smith, J ;
O'Brien, P ;
Davis, S ;
Ryan, G ;
Olver, I ;
Toner, G ;
Walker, Q ;
Joseph, D .
RADIOTHERAPY AND ONCOLOGY, 1999, 52 (02) :129-136
[5]  
BAUMANN M, 1996, STRAHLENTHER S1, V172, P74
[6]   Applications of two-step intensity modulated arc therapy [J].
Bratengeier, K .
STRAHLENTHERAPIE UND ONKOLOGIE, 2001, 177 (08) :394-403
[7]   FITTING OF NORMAL TISSUE TOLERANCE DATA TO AN ANALYTIC-FUNCTION [J].
BURMAN, C ;
KUTCHER, GJ ;
EMAMI, B ;
GOITEIN, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :123-135
[8]   Predictive factors in radiotherapy for non-small cell lung cancer: present status [J].
Choi, N ;
Baumann, M ;
Flentjie, M ;
Kellokumpu-Lehtinen, P ;
Senan, S ;
Zamboglou, N ;
Kosmidis, P .
LUNG CANCER, 2001, 31 (01) :43-56
[9]  
Choy H, 1999, SEMIN RADIAT ONCOL, V9, P90
[10]   EVALUATION OF ADJUVANT POSTOPERATIVE RADIOTHERAPY FOR LUNG-CANCER [J].
CHUNG, CK ;
STRYKER, JA ;
ONEILL, M ;
DEMUTH, WE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (11) :1877-1880